BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for ...

The bloc has now paused implementation three times, with the latest moratorium coming after reaching a framework deal with ...